Today we will digest Ihh Healthcare. We will cover the possibilities of making Ihh Healthcare into a steady grower in July. Ihh Healthcare Bhd odds of financial turmoil is under 16 percent. Assuming the 30 trading days horizon, Ihh Healthcare is expected to generate 3.53 times less return on investment than the market. But when comparing it to its historical volatility, the company is 1.13 times less risky than the market. It trades about 0.03 of its potential returns per unit of risk. The market is currently generating roughly 0.11 of returns per unit of risk over similar time horizon. Ihh Healthcare Bhd probability of distress is under 16 percent. We consider Ihh Healthcare risky.
Ihh Healthcare Bhd holds Efficiency (Sharpe) Ratio of 0.0345, which attests that the entity had 0.0345% of return per unit of risk over the last 1 month. Our philosophy towards determining the volatility of a stock is to use all available market data together with stock specific
technical indicators that cannot be
diversified away. We have found twenty-one
technical indicators for Ihh Healthcare Bhd, which you can use to evaluate future volatility of the firm. Please check out Ihh Healthcare
risk adjusted performance of 0.0715, and
market risk adjusted performance of 0.5335 to validate if the risk estimate we provide is consistent with the expected return of 0.0661%.
Ihh Healthcare classifies itself under
Healthcare sector and is part of
Medical Care Facilities industry. This firm has accumulated 1.74
B in total debt with debt to equity ratio (D/E) of 0.4, which is about average as compared to similar companies. The company has a current ratio of 1.4, which is within standard range for the sector. Ihh Healthcare harnesses its resources almost 2.8 (percent), generating $0.028 for each dollar of resources held by the firm. An expanding asset utilization attests that the company is being more effective with each dollar of resources it retains. Simply put asset utilization of Ihh Healthcare shows how effective it operates for each dollar spent on its resources.
Please consider monitoring IHH Healthcare on a daily basis if you are holding a position in it. IHH Healthcare is trading at a penny-stock level, and the possibility of delisting is much higher compared to other pink sheets. However, just because the pink sheet is trading under one dollar, does not mean it will be marked for deletion.
Most exchanges require public instruments, such as IHH Healthcare stock to be traded above the $1 level to remain listed. If IHH Healthcare pink sheet price falls below $1 for 30 consecutive trading days, the exchange can delist it. Once the company reaches this point, they will be sent an initial price violation notice directly from an exchange.
IHH Healthcare
financial leverage refers to using borrowed capital as a funding source to finance IHH Healthcare Berhad ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. IHH Healthcare financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to IHH Healthcare's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of IHH Healthcare's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the
breakdown between IHH Healthcare's total debt and its cash.
To perform a cash flow analysis of IHH Healthcare, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash IHH Healthcare is receiving and how much cash it distributes out in a given period. The IHH Healthcare cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.
Ihh Healthcare preserves 357.50 x of price to earning. Ihh Healthcare Bhd reported revenue of 2.79
B. Net Income was 33.18
M with profit before overhead, payroll, taxes, and interest of 5.03
B. Ihh Healthcare is selling for under 1.35. Day highest price was 1.35.
Our Final Take On Investing in Ihh Healthcare
While many of the other players under medical care facilities industry are still a little expensive, even after the recent corrections, Ihh Healthcare may offer a potential longer-term growth to investors. All in all, as of 29th of June 2020, we believe Ihh Healthcare is currently
fairly valued. It barely shadows the market and projects
low chance of distress in the next two years. Our final 30 days buy/sell recommendation on the firm is
Hold. With somewhat neutral outlook on your 30 days horizon, it may be better to hold off any trading activity and neither buy new shares of IHHHF or drop your existing holdings in the OTC Stock. It seems the expected volatility has not yet been fully factored into the current price. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Ihh Healthcare.
Raphi Shpitalnik is a Junior Member of Macroaxis Editorial Board. Raphael is a young entrepreneur who joined Macroaxis on a part-time basis at the beginning of the pandemic and eventually acquired a real taste for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of IHH Healthcare Berhad. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com